Studie

Senolytika decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease

Hickson LJ, Langhi Prata LGP, Bobart SA, et al.

PRIMÄR Tier 4 2019
StudiedesignPRIMÄR
TierTier 4, Animal or preclinical only
År2019
TidskriftEBioMedicine
N1
Tillagd i NO1GEVITYjun 11, 2026

Läs källan

Citerad av

1 encyklopediartiklar refererar till denna studie.